Transdiagnostic Sleep and Anxiety Treatment

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

61 participants

Study Classification

INTERVENTIONAL

Study Start Date

2017-08-01

Study Completion Date

2018-05-12

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Background: Anxiety and insomnia disorders are two of the most common and costly mental health conditions. These disorders are frequently comorbid, but current treatment approaches do not target both. To streamline treatment for these commonly comorbid conditions, a novel, computerized intervention was developed targeting a transdiagnostic factor, safety aids, which are cognitive or behavioral strategies individuals use to cope with distress associated with anxiety or insomnia, that paradoxically exacerbate symptoms. A randomized controlled trial was conducted to determine the acceptability and efficacy of this newly developed intervention. Method: Young adults (N = 61) with elevated anxiety and insomnia symptoms were randomized to receive the anxiety-insomnia intervention or a computerized control condition focused on general physical health behaviors. After the intervention, participants were followed up at one week and one month and completed self-report measures.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Metacognitive Therapy for Comorbid Insomnia

NCT00235365

Secondary Insomnia

WITHDRAWN NA

Transdiagnostic CBT-I on Comorbid Depression and Insomnia

NCT05630261

Insomnia Depression

UNKNOWN NA

Implementing and Sustaining a Transdiagnostic Sleep and Circadian Treatment

NCT03556878

Sleep Disorders, Circadian Rhythm Sleep Disorder Acceptability +3 more

COMPLETED NA

Sleep Treatment Outcome Predictors: A Pilot Study (STOP-pilot)

NCT03062891

Sleep Problem

COMPLETED NA

Assessing Modified CBTi in Adults with Insomnia Disorder

NCT06600516

Insomnia Disorder Cognitive Functioning

RECRUITING NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Anxiety Disorders

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

FSET Anxiety and Sleep Treatment

The FSET Anxiety and Sleep Treatment (FAST) is a brief, 45-minute computerized intervention that can be accessed by any device connected to the Internet. The majority of the information is delivered via text. The program contains some interactive features such as quizzes, which direct participants to content, personalized to the individual user (for example screenshots, see Figure 2). FAST contains four modules: motivation, psychoeducation, behavioral tools, and behavior change.

Group Type EXPERIMENTAL

FSET Anxiety and Sleep Treatment

Intervention Type OTHER

Computerized anxiety and insomnia intervention.

Control

The control condition is the Physical Health Education Treatment (PHET) used in several of our laboratory's prior studies (Schmidt, Capron, Raines, \& Allan, 2014). PHET is also a 45-minute computerized intervention, including audio and visual features as well as comprehension quizzes.

Group Type ACTIVE_COMPARATOR